|
|
Volumn 20, Issue 17-18, 2001, Pages 2697-2708
|
|
Enhancing the value delivered by the statistician throughout drug discovery and development: Putting statistical science into regulated pharmaceutical innovation
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTICONVULSIVE AGENT;
NEW DRUG;
ACCURACY;
ARTICLE;
COMMERCIAL PHENOMENA;
CONTROLLED STUDY;
DRUG COST;
DRUG INDUSTRY;
DRUG MARKETING;
DRUG RESEARCH;
DRUG SCREENING;
DRUG SURVEILLANCE PROGRAM;
HEALTH CARE NEED;
HEALTH CARE QUALITY;
HEALTH STATISTICS;
HUMAN;
INFORMATION PROCESSING;
INFORMATION SCIENCE;
INTERPERSONAL COMMUNICATION;
MATHEMATICAL ANALYSIS;
MEDICAL CARE;
MEDICAL DECISION MAKING;
MEDICAL INFORMATION;
MEDICAL TECHNOLOGY;
MOLECULAR GENETICS;
PREDICTION;
QUALITY CONTROL;
SOMATIC CELL GENETICS;
STATISTICAL ANALYSIS;
STATISTICAL CONCEPTS;
CARDIOVASCULAR DISEASES;
CLINICAL TRIALS;
DECISION MAKING;
DRUG EVALUATION;
DRUG INDUSTRY;
EPILEPSY;
HUMANS;
STATISTICS;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
|
EID: 0035884656
PISSN: 02776715
EISSN: None
Source Type: Journal
DOI: 10.1002/sim.737 Document Type: Article |
|
Times cited : (10)
|
|
References (2)
|
